Large breasts a cancer risk: study

July 25, 2012
Large breasts a cancer risk:  study

(Medical Xpress) -- Women with large breasts have a higher incidence of breast cancer than those with average-sized breasts, according to a study by medical students and researchers at The University of Western Australia and BreastScreen WA.

Corresponding author UWA Clinical Associate Professor Liz Wylie said the study highlighted the importance of regular for all women, but particularly those with large breasts.

Breast cancer is the most common cancer among Australian women and the second most common cause of cancer-related deaths.  As it is a non-preventable disease, early detection is vital.

Women with large breasts may be more likely to suffer breast cancer because there is more tissue available for neoplastic change and/or because larger breasts cause increased oestrogen levels.  As women age, a larger proportion of them have larger breasts.

In the study published recently by The Breast journal, data from almost 760,000 women aged from 40 to over 70 - of whom almost 55,000 had large breasts - was analysed.  Women whose breasts had been surgically enlarged or reduced and those with a previous diagnosis of breast or ovarian cancer were not included in the study.

Large breasts were defined as those that required bigger mammogram film cassettes.  Standard cassettes measure 18 x 24cm while bigger ones are 24 x 30cm.

Associate Professor Wylie said the study was noteworthy because Australia is facing an obesity epidemic.  An increased body mass index is associated with a higher risk of developing post-menopausal .

The study is entitled "Outcome of mammography in with large breasts" and its three leading authors are UWA .

Explore further: Preop MRI valuable in detecting additional malignancies in dense & not dense breasts

Related Stories

Preop MRI valuable in detecting additional malignancies in dense & not dense breasts

May 4, 2012
Newly diagnosed breast cancer patients should undergo a preoperative MRI exam even if their breasts are not dense, a new study indicates. The study found no difference between the usefulness of 3T breast MRI in detecting ...

Combo hormone therapy has increased breast cancer risk over estrogen alone

November 18, 2011
The debate about using menopausal hormone therapies to relieve symptoms in post-menopausal women has been ongoing. Is the combination therapy of estrogen and progestin better or worse than just giving women estrogen alone? ...

Recommended for you

Cancer-death button gets jammed by gut bacterium

July 27, 2017
Researchers at Michigan Medicine and in China showed that a type of bacterium is associated with the recurrence of colorectal cancer and poor outcomes. They found that Fusobacterium nucleatum in the gut can stop chemotherapy ...

Researchers release first draft of a genome-wide cancer 'dependency map'

July 27, 2017
In one of the largest efforts to build a comprehensive catalog of genetic vulnerabilities in cancer, researchers from the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute have identified more than 760 genes ...

Long-sought mechanism of metastasis is discovered in pancreatic cancer

July 27, 2017
Cells, just like people, have memories. They retain molecular markers that at the beginning of their existence helped guide their development. Cells that become cancerous may be making use of these early memories to power ...

Blocking the back-door that cancer cells use to escape death by radiotherapy

July 27, 2017
A natural healing mechanism of the body may be reducing the efficiency of radiotherapy in breast cancer patients, according to a new study.

Manmade peptides reduce breast cancer's spread

July 27, 2017
Manmade peptides that directly disrupt the inner workings of a gene known to support cancer's spread significantly reduce metastasis in a mouse model of breast cancer, scientists say.

Glowing tumor technology helps surgeons remove hidden cancer cells

July 27, 2017
Surgeons were able to identify and remove a greater number of cancerous nodules from lung cancer patients when combining intraoperative molecular imaging (IMI) - through the use of a contrast agent that makes tumor cells ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.